Drug Companies
-
{
- All
- News
- Videos
-
Trump Imposes 100% Tariffs On Foreign-Made Drugs, Reshapes Metal Duties
Large companies will have 120 days to commit to "reshoring plans" before the steep duty kicks in, while smaller companies have a 180-day buffer, a senior US official told reporters.
-
US Company Recalls Chocolate Products Containing Hidden Erectile Dysfunction Drugs
A California-based company recalled chocolate products that contained "undeclared" pharmaceutical ingredients, sildenafil and tadalafil.
-
US, Israeli Strikes Hit Iranian Company Producing Cancer Drugs
One of the largest companies producing anti-cancer, anaesthetic and specialised medicines was damaged in US-Israeli strikes, Iran claims in an X post.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
American Company Books Every US-Bound Flight To Evacuate Employee Amid Mexico Unrest
The employee, Andrew Barba, shared his appreciation for the extraordinary effort in a post on X.
-
Trump Imposes 100% Tariffs On Foreign-Made Drugs, Reshapes Metal Duties
Large companies will have 120 days to commit to "reshoring plans" before the steep duty kicks in, while smaller companies have a 180-day buffer, a senior US official told reporters.
-
US Company Recalls Chocolate Products Containing Hidden Erectile Dysfunction Drugs
A California-based company recalled chocolate products that contained "undeclared" pharmaceutical ingredients, sildenafil and tadalafil.
-
US, Israeli Strikes Hit Iranian Company Producing Cancer Drugs
One of the largest companies producing anti-cancer, anaesthetic and specialised medicines was damaged in US-Israeli strikes, Iran claims in an X post.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections For Diabetes, Weight Management
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
American Company Books Every US-Bound Flight To Evacuate Employee Amid Mexico Unrest
The employee, Andrew Barba, shared his appreciation for the extraordinary effort in a post on X.
